A case of bowel-associated dermatosis-arthritis syndrome treated with ustekinumab: The importance of targeting underlying gastrointestinal disease
Main Authors: | Matthew Heard, MHS, Myron Zhang, MD, Joseph L. Jorizzo, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512620302617 |
Similar Items
-
Ustekinumab in patients with Crohn’s disease with extraintestinal manifestations (psoriasis)
by: P. A. Makarchuk, et al.
Published: (2020-10-01) -
Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
by: An-Yu Chen, et al.
Published: (2019-09-01) -
Posterior Reversible Encephalopathy Syndrome following Ustekinumab Induction for Crohn’s Disease
by: Avantika Mishra, et al.
Published: (2018-08-01) -
How to Optimize Treatment With Ustekinumab in Inflammatory Bowel Disease: Lessons Learned From Clinical Trials and Real-World Data
by: Ana Gutiérrez, et al.
Published: (2021-01-01) -
INFLAMMATORY BOWEL DISEASE: CYTOCHEMICAL ACTIVITY OF INTRACELLULAR ENZYMES OF PERIPHERAL BLOOD NEUTROPHILS AND MONOCYTES IN DIAGNOSIS
by: V. A. ЕMELYANOVA, et al.
Published: (2017-09-01)